Tumor Xenografts of Human Clear Cell Renal Cell Carcinoma But Not Corresponding Cell Lines Recapitulate Clinical Response to Sunitinib: Feasibility of Using Biopsy Samples

Yiyu Dong(Memorial Sloan Kettering Cancer Center), James J. Hsieh(Memorial Sloan Kettering Cancer Center), Ömer Aras(Memorial Sloan Kettering Cancer Center), Darren R. Feldman(Memorial Sloan Kettering Cancer Center), Almedina Redzematovic(Memorial Sloan Kettering Cancer Center), Chung‐Han Lee(Memorial Sloan Kettering Cancer Center), John H. Healey(Memorial Sloan Kettering Cancer Center), Paul Russo(Memorial Sloan Kettering Cancer Center), Jeremy C. Durack(Memorial Sloan Kettering Cancer Center), Patrick J. Boland(Memorial Sloan Kettering Cancer Center), Maria E. Arcila(Memorial Sloan Kettering Cancer Center), Jozefina Casuscelli(LMU Klinikum), Robert J. Motzer(Memorial Sloan Kettering Cancer Center), Daniel Tennenbaum(Memorial Sloan Kettering Cancer Center), Mohit Chawla(Memorial Sloan Kettering Cancer Center), Nicole Benfante, Nicola Fabbri(Memorial Sloan Kettering Cancer Center), Jonathan Coleman(Memorial Sloan Kettering Cancer Center), Ed Reznik(Icahn School of Medicine at Mount Sinai), A. Ari Hakimi(Penn State Milton S. Hershey Medical Center), Martin H. Voss(Memorial Sloan Kettering Cancer Center), Song Han(Memorial Sloan Kettering Cancer Center), Emily H. Cheng(University of Wisconsin–Madison), Ying‐Bei Chen(Memorial Sloan Kettering Cancer Center), Maria F. Becerra(Memorial Sloan Kettering Cancer Center), Brandon J. Manley(Moffitt Cancer Center)

European Urology Focus

September 9, 2016

Cited by 36

|New England Journal of Medicine|2018|4.6k

|Nature Genetics|2019|4.4k

|Cell|2015|3.6k

|JCO Precision Oncology|2017|2.7k

|Science Translational Medicine|2014|2.5k

Related Papers